Main Article Content


Inflammation in asthma occurs due to the activation of various cells that produce proinflammatory cytokines. Corticosteroid treatment can affect bone formation, impacting vitamin D levels and alkaline phosphatase (ALP) enzyme activity. This study aimed to evaluate the decrease in vitamin D and increase in ALP due to inflammatory events characterized by an increase in interleukin-17A (IL-17A). The research design is a case-control design. Thirty-four adults with asthma and 34 healthy controls were monitored for blood through laboratory testing. Comparative and correlation statistics were analyzed using Medcalc ver. 19.0.7. All three laboratory parameters showed significant differences between the asthmatic and control groups (P < 0.05). Each vitamin D and ALP gave a good correlated wellults of the IL-17A examination (r = -0.2950; P = 0.015 and r = 0.2590; P = 0.033). There is no significant correlation between Vitamin D and ALP (r = -0.0483; P = 0.696). Moreover, ALP showed a low sensitivity (32%) in identifying vitamin D deficiency in asthmatic patients.


Asthma inflammation vitamin D deficiency alkaline phosphatase

Article Details

How to Cite
Simanjuntak JP, Sakdiah S, Sitanggang FT, Maharani EA. Investigation Activities of Vitamin D, Interleukin-17A, and Alkaline Phosphatase as Biological Markers in Asthma. EKSAKTA [Internet]. 2023Apr.15 [cited 2023Jun.6];24(02):154-6. Available from:


  1. Agache, I., & Akdis, C. A. (2021). 2nd Edition Global Atlas of Asthma. European Academy of Allergy and Clinical Immunology (EAACI), April, 1–344.
  2. Ahmed, A. A., & Ad’hiah, A. H. (2021). Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19). Cytokine, 148, 155702.
  3. Alkhatatbeh, M. J., Almomani, H. S., Abdul-Razzak, K. K., & Samrah, S. (2021). Association of asthma with low serum vitamin D and its related musculoskeletal and psychological symptoms in adults: a case-control study. Npj Primary Care Respiratory Medicine, 31(1), 1–8.
  4. Bellastella, G., Scappaticcio, L., Longo, M., Carotenuto, R., Carbone, C., Caruso, P., Maio, A., Paglionico, V. A., Vietri, M. T., & Maiorino, M. I. (2021). New insights into vitamin D regulation: is there a role for alkaline phosphatase? Journal of Endocrinological Investigation, 1–6.
  5. Jacquillet, G., & Unwin, R. J. (2019). Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi). Pflügers Archiv-European Journal of Physiology, 471, 83-98.
  6. Bener, A., Ehlayel, M. S., Bener, H. Z., & Hamid, Q. (2014). The impact of Vitamin D deficiency on asthma, allergic rhinitis and wheezing in children: An emerging public health problem. Journal of Family and Community Medicine, 21(3), 154–161.
  7. Forno, E., Bacharier, L. B., Phipatanakul, W., Guilbert, T. W., Cabana, M. D., Ross, K., ... & Celedón, J. C. (2020). Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: the VDKA randomized clinical trial. Jama, 324(8), 752-760.
  8. Andújar-Espinosa, R., Salinero-González, L., Illán-Gómez, F., Castilla-Martínez, M., Hu-Yang, C., & Ruiz-López, F. J. (2021). Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax, 76(2), 126-133.
  9. Caterino, M., Gelzo, M., Sol, S., Fedele, R., Annunziata, A., Calabrese, C., Fiorentino, G., D’Abbraccio, M., Dell’Isola, C., & Fusco, F. M. (2021). Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Scientific Reports, 11(1), 1–10.
  10. Merad, M., & Martin, J. C. (2020). Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nature reviews immunology, 20(6), 355-362.
  11. Stark, K., & Massberg, S. (2021). Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews Cardiology, 18(9), 666-682.
  12. Duarte, C., Carvalheiro, H., Rodrigues, A. M., Dias, S. S., Marques, A., Santiago, T., Canhão, H., Branco, J. C., & da Silva, J. A. P. (2020). Prevalence of vitamin D deficiency and its predictors in the Portuguese population: a nationwide population-based study. Archives of Osteoporosis, 15, 1–11.
  13. Enilari, O., & Sinha, S. (2019). The global impact of asthma in adult populatio. Annals of Global Health, 85(1), 1–7.
  14. Dimitrova, D., Youroukova, V., Ivanova-Todorova, E., Tumangelova-Yuzeir, K., & Velikova, T. (2019). Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma. Respiratory Medicine, 154, 144–154.
  15. Domvri, K., Porpodis, K., Tzimagiorgis, G., Chatzopoulou, F., Kontakiotis, T., Kyriazis, G., & Papakosta, D. (2019). Th2/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation. Respiratory Medicine, 151, 102–110.
  16. Gupta, G., Shareef, I., Tomar, S., Kumar, M. S. N., Pandey, S., Sarda, R., ... & Sinha, S. (2022). Th1/Th2/Th17 cytokine profile among different stages of COVID-19 infection. National Academy Science Letters, 45(4), 363-369.
  17. Serebrisky, D., & Wiznia, A. (2019). Pediatric asthma: a global epidemic. Annals of global Health, 85(1).
  18. Guo, J., Wang, F., Hu, Y., Luo, Y., Wei, Y., Xu, K., Zhang, H., Liu, H., Bo, L., & Lv, S. (2023). Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Reports Medicine, 100881.
  19. Asher, M. I., García-Marcos, L., Pearce, N. E., & Strachan, D. P. (2020). Trends in worldwide asthma prevalence. European Respiratory Journal, 56(6).
  20. Chinratanapisit, S., Suratannon, N., Pacharn, P., Sritipsukho, P., & Vichyanond, P. (2019). Prevalence and severity of asthma, rhinoconjunctivitis and eczema in children from the Bangkok area: The Global Asthma Network (GAN) Phase I. Asian Pac J Allergy Immunol, 37(4), 226-231.
  21. Bissell, K., Ellwood, P., Ellwood, E., Chiang, C. Y., Marks, G. B., El Sony, A., ... & Global Asthma Network Study Group. (2019). Essential medicines at the national level: The global asthma network’s essential asthma medicines survey 2014. International journal of environmental research and public health, 16(4), 605.
  22. Karrar, M. H., Noureddin, M. A., Alhaddad, A. T., & Alshumaymiri, N. I. (2021). Lack of correlation between vitamin D and. January.
  23. Walsh, J. S., Bowles, S., & Evans, A. L. (2017). Vitamin D in obesity. Current Opinion in Endocrinology & Diabetes and Obesity, 24(6), 389-394.
  24. Kementerian Kesehatan RI. (2019). Penderita Asma di Indonesia. Infodatin Kemenkes RI (2019) I.
  25. Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019). The Cytokines of Asthma. Immunity, 50(4), 975–991.
  26. Mitchell, P. D., & O’Byrne, P. M. (2017). Epithelial-derived cytokines in asthma. Chest, 151(6), 1338-1344.
  27. Özkars, M. Y. (2019). The relationship between serum vitamin D level and asthma. Northern Clinics of Istanbul, 6(4), 334–340.
  28. Ali, N. S., & Nanji, K. (2017). A review on the role of vitamin D in asthma. Cureus, 9(5).
  29. Liu, J., Dong, Y. Q., Yin, J., Yao, J., Shen, J., Sheng, G. J., ... & Wu, W. F. (2019). Meta-analysis of vitamin D and lung function in patients with asthma. Respiratory research, 20(1), 1-11.
  30. Beyhan-Sagmen, S., Baykan, O., Balcan, B., & Ceyhan, B. (2017). Association between severe vitamin D deficiency, lung function and asthma control. Archivos de Bronconeumología (English Edition), 53(4), 186-191.
  31. Lv, X., Liu, N., & Yin, Z. (2020). Serum 25 hydroxyvitamin D, Bone Alkaline Phosphatase, Bone Mineral Content and Bone Mineral Density as Important Biochemical Markers for Diagnosis of Nutritional Rickets. International Journal of Early Childhood Special Education (INT-JECSE), Volume 29(Issue 4), 365-.
  32. Akbar, M. R., Wibowo, A., Pranata, R., & Setiabudiawan, B. (2021). Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Frontiers in nutrition, 8, 660420.
  33. Schumann, G., Klauke, R., Canalias, F., Bossert-Reuther, S., Franck, P. F. H., Gella, F. J., Jørgensen, P. J., Kang, D., Lessinger, J. M., Panteghini, M., & Ceriotti, F. (2011). IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 9: Reference procedure for the measurement of catalytic concentration of alkaline phosphatase International Federation of Clinical Chemistr. Clinical Chemistry and Laboratory Medicine, 49(9), 1439–1446.
  34. Song, P., Adeloye, D., Salim, H., Dos Santos, J. P., Campbell, H., Sheikh, A., & Rudan, I. (2022). Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. Journal of Global Health, 12, 04052.
  35. Thacher, T. D., Sempos, C. T., Durazo-Arvizu, R. A., Fischer, P. R., Munns, C. F., & Pettifor, J. M. (2021). The Validity of Serum Alkaline Phosphatase to Identify Nutritional Rickets in Nigerian Children on a Calcium-Deprived Diet. Journal of Clinical Endocrinology and Metabolism, 106(9), E3559–E3564.
  36. Vasudevan, J., Jenifer, A., Reddy, G. M. M., & Thayumanavan, S. (2014). Serum alkaline phosphatase for screening of hypovitaminosis D. Indian Pediatrics, 51(1), 60–61.
  37. Cepelis, A., Brumpton, B. M., Laugsand, L. E., Dalen, H., Langhammer, A., Janszky, I., & Strand, L. B. (2019). Asthma, asthma control and risk of acute myocardial infarction: HUNT study. European Journal of Epidemiology, 34, 967–977.
  38. Cevhertas, L., Ogulur, I., Maurer, D. J., Burla, D., Ding, M., Jansen, K., Koch, J., Liu, C., Ma, S., & Mitamura, Y. (2020). Advances and recent developments in asthma in 2020. Allergy, 75(12), 3124–3146.
  39. Dalton, B. R., Rajakumar, I., Langevin, A., Ondro, C., Sabuda, D., Griener, T. P., Dersch-Mills, D., & Rennert-May, E. (2020). Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity. Clinical Microbiology and Infection, 26(4), 436–446.